Everything you need to register and maintain your products across the continent.

Four capabilities.
One integrated practice.

Regulatory Consulting

Strategy, pathway analysis, and marketing authorisation support across 20+ African markets — from first-market entry to full product lifecycle management.

Local Technical Representative (LTR)

In-country registration and ongoing maintenance across Africa. One contract with Shaami covers every market. Pan-African coverage, one point of accountability.

Mock Inspections & GxP Compliance

Preparing manufacturers for stringent regulatory approvals, WHO Prequalification, Expert Review Panel and inspections by regulators across Africa — gap analysis, process remediation, and sustained compliance capability.

Regulatory Spotlight & Intelligence

Africa’s leading regulatory intelligence newsletter. 3,000+ subscribers. 16 editions. The continent’s most-read regulatory briefing, published monthly.

AFRICA’S REGULATORY INTELLIGENCE BRIEFING

The Shaami Regulatory Spotlight

Issue 16 · Monthly · Free3,000+ subscribers worldwide

Zazibona GMP, Egypt–SA work sharing, and Ethiopia’s revised framework

Botswana hosts Zazibona GMP work-sharing with 11 SADC inspectors. Egypt and SAHPRA launch biologicals pilot. Ethiopia shifts to 3-year risk-based cycles. Zimbabwe–Zambia MoU formalised.

Assessment tool

Africa has 55 countries, dozens of pathways, and almost no central source of truth.

Shaami is the only regulatory intelligence tool built for Africa. 15 markets in depth, with curated pathway data across all 55.

Field notes, built in

Years of MAA filing intelligence in every answer. What regulators publish vs what they do. What timelines look like. The costs nobody tells you about upfront.

Markets15 in depth · 54 tracked
Sources300+ official · refreshed weekly
ProductsMedicines · biologicals · devices · IVDs · SaMD · herbals
PathwaysFull · abridged · reliance · fast-track · emergency · joint
Try Shaami → Free during pilot
Live demo
Shaami. by Market Access Africa Preview
Kenya PPB Zimbabwe MCAZ Nigeria NAFDAC South Africa SAHPRA Ghana FDA Rwanda FDA Tanzania TMDA Senegal ARP Côte d’Ivoire AIRP Cameroon DPML Ethiopia EFDA Botswana BOMRA Mozambique ANARME Malawi PMRA Angola ARMED
Full assessment
Ask a question
Share experience
Regulatory assessment
Pathway analysis
Category
Innovator/generic
Location
GMP cert
Generate my assessment
Assessment readygenerated in 12s
Ask Shaami
Conversational regulatory intelligence across 15 markets
Export chatNew chat
Ask anything about African regulatory markets...SEND →
Sources cited
Scenario 1 of 6
What clients say

Trusted by health product companies worldwide

“Working with Shaami gave us a level of regulatory confidence we didn’t expect. Our NAFDAC submission was handled professionally from end to end — no surprises, no delays we weren’t warned about in advance.”

JM
J. Muller
Regulatory Director, Diagnostics Company

“The Spotlight newsletter is genuinely the best source we’ve found for tracking African regulatory developments. It changed how our team thinks about Africa market access strategy.”

SB
S. Botha
Market Access Manager, Digital Health Platform

“Having one partner handle both the regulatory strategy and in-country LTR across multiple African markets simplified our Africa entry enormously. We could focus on the product, not the paperwork.”

AT
A. Thorpe
VP Regulatory Affairs, IVD Manufacturer
Ready to start

Your product belongs in
every African market it can reach.

Tell us which markets matter, what you’re registering, and your timeline. We respond within five business days.

Our capabilities

Regulatory expertise,
built for Africa.

Four integrated capabilities that cover the full regulatory lifecycle — from first-market strategy to continental registration and ongoing compliance. Informed by lived experience of African regulatory environments and global best practice standards.

Who we are

Shaami is the regulatory practice of Market Access Africa.

We bring together regulatory consulting, in-country representation, compliance readiness, regulatory intelligence, and systems strengthening under one roof — serving manufacturers, national regulatory authorities, regional bodies, and global health institutions across the African continent.

Our work spans collaborations with leading global health institutions, development finance partners, philanthropic organisations, national regulatory authorities, pharmaceutical and medical device manufacturers, and emerging biotech and digital health companies. We don’t view regulatory affairs as a compliance exercise. We treat it as the strategic lever that determines whether a product reaches the patients who need it — and how fast.

This breadth of engagement gives us something few firms can claim: a systems-level understanding of how regulatory policy, innovation, commercial strategy, and patient access intersect across Africa’s most consequential markets. We use that understanding to deliver transformative outcomes — not just for individual product pathways, but for the health ecosystem itself.

Our services

Four capabilities.
One integrated practice.

01.
Regulatory Consulting
Get the pathway right before you spend on registration.
Strategy & feasibility
African market-entry roadmaps
Country prioritisation
Product classification (pharma, devices, IVDs, SaMD, supplements, cosmetics)
Feasibility & submission-readiness
Briefing books & investigator brochures
Submissions & medical writing
MA application support
Dossier preparation & gap analysis
eCTD, NeeS & paper submissions
Drug Master File submissions
CSRs & eCTD module 2 summaries
Labeling & core data sheets
Toxicology & impurity justification
Lifecycle, queries & clinical trials
HA interactions & RtQs
Variations, renewals & horizon scanning
Clinical trial regulatory strategy
Protocol development support
Regulatory due diligence
02.
LTR / LAR & MAH Services
We hold your authorisation. We never touch your distribution.
Coverage & liaison
Named LTR & MAH
Independent MAH with distributor flexibility
Continuous regulator dialogue
Legal representative changes
Regional bloc pre-submission engagement
Submissions, renewals & translation
Submission management & launch sequencing
Annual registration renewals
Marketing authorisation transfers
In-country sample testing
Import permits & licences
Translations (French, Portuguese, Arabic, Swahili)
Country-specific QMS compliance
Pharmacovigilance & post-market
Adverse event case processing
Periodic safety reports (PSUR / PBRER)
PMS, PMCF & PMPF for devices
Recall coordination & FSCAs
UDI compliance for medical devices
Filing fees passed through at cost
Portfolio pricing scales down
03.
Quality & Compliance
Pass the inspection that hasn’t happened yet.
WHO PQ readiness
Pre-audit preparation
WHO PQ mock inspections
On-site audit support
Post-audit CAPA
Response to PQ observations
Site Master File preparation
Inspection readiness
Pre-inspection gap analysis
Mock GMP, GCP, GLP & GxP audits
MDSAP audit support
Clinical trial site readiness
Post-inspection remediation
Quality systems & validation
QMS development & review
ISO 13485, IEC 62304, ISO 14971
Process & product validation
Computer system validation (CSV)
Design history files
Scientific advice facilitation
Manufacturing & QA training
04.
NRA Services & Regulatory Intelligence
Strengthen the regulators. Inform the market.
NRA strengthening
WHO GBT assessments & ML advancement
IDPs toward WHO ML3 & ML4
Financial sustainability planning
Revenue diversification strategies
Business development for NRAs
NRA-to-NRA matchmaking
Workforce capability planning
Organisational design
Process digitalisation
Capacity building
Bioequivalence training (flagship)
Advanced regulatory science training
Peer-to-peer NRA exchanges
Pharma RA team training
The Spotlight & briefings
The Shaami Spotlight (monthly, free)
3,000+ subscribers worldwide
Bespoke intelligence briefings
The Shaami Collective

A practice is the people who do the work.

Shaami works through a deliberate mix of in-house experts, trusted consultants, and partner organisations across the continent. We don’t pretend to know everything — we make sure the right person, and the right institution, is on every engagement.

Loice Kikwai, Ph.D.
Shaami
Loice Kikwai, Ph.D.
Built her career at
US FDA (Office of Generic Drugs), US Pharmacopeia, LCK Pharmaceutical Consulting
Expertise
Bioequivalence assessment·CMC and quality standards·generic pharma regulation
Sarah Achola Muthuri
Shaami
Sarah Achola Muthuri
Built her career at
Novartis (Head, East Africa Regulatory Affairs), GlaxoSmithKline, IAVI
Expertise
East African regulatory strategy·clinical trial regulatory affairs·government affairs
Shireen Haroon
Shaami
Shireen Haroon
Built her career at
Abbott Rapid Diagnostics (Director, RA Africa), Abbott Diagnostics, Alere Healthcare
Expertise
IVD & medical device regulation·WHO Prequalification·ISO 13485 quality systems
Merle Kock
Affiliate
Merle Kock
Built her career at
Aspen Pharmacare (Head of Quality, Responsible Pharmacist), Amekh Group (Co-Founder & Director)
Expertise
GMP/GxP inspections·quality management systems·SAHPRA, FDA & WHO compliance
Bakani Ncube
Shaami
Bakani Ncube
Built his career at
African medicines regulatory authorities, regional harmonisation initiatives, pharmaceutical industry
Expertise
In-country delivery·NRA engagement·priority-market rollout
Uduak Inokon, Pharm.D.
Affiliate
Uduak Inokon, Pharm.D.
Built her career at
US FDA (CDER Office of Pharmaceutical Quality, San Francisco District), US Public Health Service (Captain Ret.), ICGMP (Founder & Principal)
Expertise
FDA GMP inspections, domestic & international·pharmaceutical quality compliance·DSCSA, ICH Q13 & pre-approval inspections
Mwai Ngibuini
Affiliate
Mwai Ngibuini
Built his career at
IAVI (Director of Program Management), US Pharmacopeia (Senior Regional Technical Advisor, Vaccines & Biologics), Merck KGaA Sub-Sahara Africa, EMKEI Innovations
Expertise
Vaccine & biologics manufacturing·lot release principles & protocols·WHO Maturity Level 3 regulatory strengthening
Rukia Marijani
Affiliate
Rukia Marijani
Built her career at
US FDA (Office of Generic Drugs)
Expertise
Inhalation dosage forms·generic drug development·FDA generic drug regulatory affairs
GO
Affiliate
Geoffrey Okelo
Built his career at
Uniquity Bio (Director, Regulatory Affairs), Pharmaron CPC (Director, Regulatory Affairs), US FDA CDER/OPQ (CMC Reviewer), Pfizer Global R&D (Scientist)
Expertise
Global regulatory strategy·IND/CTA submissions & FDA liaison·CMC review & risk-based assessment
Our growing partner network

Beyond our own bench, an institutional network across the continent.

Shaami partners with specialist agencies and consultancies to extend our reach — clinical research organisations, regulatory consultancies, and academic institutes whose work complements ours.

Pharmaceutical quality management and GMP compliance consultancy
Biomanufacturing capacity building, strategic consultancy, and local manufacturing support

Each engagement is structured to match the specific regulatory work and the right institutional capability.

Why Shaami

Built for this. Only for this.

Shaami is not a global consultancy with an Africa practice. It is an Africa practice — built from within, by people with lived experience of African health systems, regulatory bodies, and the political terrain that shapes them.

01

African by design

Deep knowledge of African regulatory environments, fluent in global best practice. We shape strategies that are practical, not just compliant.

02

Intelligence-led

The Shaami Spotlight tracks every regulatory development across all 55 African markets. Our clients see what’s changing before official announcements reach the market.

03

Full lifecycle coverage

One partner from feasibility through post-market obligations. No coordinating fifteen LTRs, no fragmented relationships across the continent.

04

Systems-level perspective

We work with NRAs and manufacturers — both sides of every submission. That dual vantage shapes how we advise on policy, innovation, and market access.

05

Diagnostic & digital focus

Deep expertise in SaMD, IVDs, and digital health — Africa’s fastest-growing registration categories, and the ones traditional pharma consultancies are least equipped to handle.

06

Swiss-backed structure

Market Access Africa, Swiss-registered, provides the commercial and liability framework. In-country entities provide the regulatory presence and accountability.

Ready to discuss your regulatory needs?

Our team responds within five business days with a clear pathway and fee proposal.

Local Technical Representative Services

Your product. Every African
market it belongs in.

One contract. Pan-African coverage. Shaami registers and maintains your products wherever in Africa they need to be — with full accountability for every obligation in every market.

What is an LTR

Your in-country regulatory anchor — everywhere in Africa

African regulators require foreign manufacturers to designate a Local Technical Representative before their products can be registered. The LTR is not a formality — it receives regulatory correspondence, submits dossiers, holds Registration Certificates, manages adverse event obligations, and is the face of your product to the regulator. Choose the wrong partner and those responsibilities become liabilities.

The risk

Why most LTR arrangements fail

i.
Multiple LTRs to manage
Every market needs its own LTR. Companies end up coordinating 10 or 15 different entities — each with its own quality, response time, and communication style.
ii.
Partners arrive unvetted
Local distributors often nominate themselves as LTRs without genuine regulatory credentials. The quality gap surfaces only when the registration is at risk.
iii.
LTR locked to distribution
Most local partners insist on holding both. When the commercial relationship sours, your registration is held hostage. Untangling means starting over.
The answer

What makes Shaami different

i.
One partner, 20+ markets
A single point of contact for the entire continent. One engagement, one team, one accountable counterparty — instead of coordinating 15 entities yourself.
ii.
Regulatory-led, fully vetted
Our partners are selected by regulatory criteria, not commercial convenience. Every entity is held to the same quality and accountability standard before client work touches it.
iii.
LTR separated from distribution
Shaami holds your regulatory authorisation without taking distribution rights. You keep your commercial relationships independent — and you can change distributors without touching your registration.
Process

Simple for you. Rigorous in execution.

You bring the products and the technical files. We handle every regulatory obligation that follows.

1

One agreement with Shaami

You sign a single master agreement. One contract covers every market, every product, and every regulatory obligation within scope — regardless of how many markets you enter.

2

Market and product assessment

Our central regulatory team reviews each product against the requirements of your target markets — classification, pathway, dossier gaps, likely timelines. We flag issues before any submission is made. No surprises on day thirty.

3

Shaami named as your in-country LTR

The relevant Shaami entity or partner is named as your authorised agent in each target market. You remain the manufacturer of record. We are your in-country representative, with full accountability for the regulatory relationship.

4

Dossiers prepared and submitted

Our central regulatory team prepares your registration dossiers, manages all regulator correspondence, responds to deficiency letters, and keeps you updated on progress. You do not need to build your own Africa regulatory team.

5

Certificates issued and maintained

Registration Certificates belong to you and are transferable at any time. Your annual maintenance fee covers all renewals, PMS obligations, adverse event reporting, and ongoing regulatory correspondence — your products stay registered and you stay compliant.

Active markets

Where we work

Operationally rooted in six African markets today, with four more launching in 2027. Continental regulatory intelligence across all 55 African markets through The Shaami Spotlight.

BW
BotswanaBoMRA · SADC
Coming 2027
CI
Côte d’IvoireAIRP · ECOWAS
Active
GH
GhanaFDA Ghana · ECOWAS
Active
KE
KenyaPPB · EAC
Active
NG
NigeriaNAFDAC · ECOWAS
Active
RW
RwandaRwanda FDA · EAC
Coming 2027
SN
SenegalARP · ECOWAS
Active
ZA
South AfricaSAHPRA · SADC
Active
ZW
ZimbabweMCAZ · SADC
Coming 2027
ZM
ZambiaZAMRA · SADC
Coming 2027
West Africa · ECOWASfour active markets
NG
NigeriaNAFDAC
Active
GH
GhanaFDA Ghana
Active
CI
Côte d’IvoireAIRP
Active
SN
SenegalARP
Active
East Africa · EACone active, one in 2027
KE
KenyaPPB
Active
RW
RwandaRwanda FDA
Coming 2027
Southern Africa · SADCone active, three in 2027
ZA
South AfricaSAHPRA
Active
ZW
ZimbabweMCAZ
Coming 2027
BW
BotswanaBoMRA
Coming 2027
ZM
ZambiaZAMRA
Coming 2027
Continental coverage

We track every African market through the Spotlight.

From North African NRAs to the smallest island states — regulatory intelligence across all 55 markets, free, every month.

Scope

What we register

Initial focus on diagnostic and digital health — the categories where regulatory complexity is highest and specialist expertise matters most.

Software as a Medical Device (SaMD)

AI diagnostics, clinical decision support, health monitoring apps and digital tools under IMDRF frameworks adopted across Africa.

In Vitro Diagnostics (IVDs)

Point-of-care tests, rapid diagnostics, laboratory assays — with a focus on infectious disease and public health gap products.

Digital health tools

Telemedicine platforms, remote patient monitoring, mHealth applications, and health data systems requiring regulatory clearance.

Low-risk medical devices

Class I and Class II devices, including low-instrumentation diagnostic equipment addressing important public health needs.

Coming soon

Pharmaceutical products

Building pharmaceutical registration capability now. Essential medicines, generics, biologics, and specialty pharmaceuticals — speak to us early and we’ll plan ahead with you.

Coming soon

Vaccines

Building vaccine registration capability now. Speak to us early — we are ready to plan ahead with you.

Commercial model

Transparent pricing. Scale rewarded.

Two fee streams. No hidden costs. No mark-up on official filing fees. And as your product portfolio grows across markets, our pricing reflects the depth of the partnership.

Fee structure
Two components. Built for predictability.
Annual Maintenanceper product, per market, paid in advance
Named LTR status, regulatory correspondence, renewals, post-market surveillance, AE reporting, recall coordination, quarterly status reports.
Ad Hoc Consultancytime-based, scoped upfront
Dossier preparation, technical file remediation, product classification, regulatory strategy, deficiency response, post-approval changes, due diligence.
Regulator filing feespassed through at cost
NAFDAC, SAHPRA, PPB, DPML, others. Invoiced separately on production of receipts. No mark-up.
Portfolio pricing scales down with volume. The more products and markets you bring to Shaami, the lower the per-product annual fee.
A worked scenario
What this might look like for a typical client.
A client with 8 products across 3 markets.
Year one: Initial registration and dossier preparation in each market. Mostly ad hoc consultancy work, scoped upfront.
From year two: Flat annual maintenance fee covers ongoing compliance for all 24 product-market pairs. Per-product rate is meaningfully lower than a single registration.
As you grow: Adding the 9th product or 4th market reduces the per-unit rate further. Portfolio pricing rewards scale.
All scenarios are scoped and quoted before work begins. We’ll model your specific portfolio in our first conversation.

Ready to register your product across Africa?

Tell us which markets you need, which products, and your timeline. We respond within five business days with a clear pathway and fee proposal.

The Shaami Regulatory Spotlight

Every issue. Every development. Searchable.

25 editions of the Shaami Spotlight, structured as an explorable archive of African regulatory intelligence. Browse by market, scan top trends, subscribe to get every issue.

Newsletter editions
Every edition, archived.
Subscribe

Get the Spotlight in your inbox every month.

Free. Published monthly. Read by 3,000+ regulatory professionals globally.

Top trends · last 12 months
What's generally been happening.
Browse by market
All markets, ranked by activity.

Want the intelligence before everyone else?

Subscribe to the Shaami Regulatory Spotlight and get every development the moment it’s published.